| NDC-11 (Package) | NDC-9 (Product) | Generic Name | Brand Name | Strength | SEER*Rx Category | Major Class | Minor Class | Administration Route | Package Effective Date | Package Discontinuation Date | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 70720-0950-36 | 70720-0950 | Goserelin | ZOLADEX | 3.6 mg/1 | Hormonal Therapy | GnRH Agonist | Subcutaneous | Mar 31, 2018 | In Use | ||
| 00074-3473-03 | 00074-3473 | Leuprolide Acetate | Lupron Depot | Hormonal Therapy | GnRH Agonist | Dec 23, 1995 | In Use | ||||
| 00023-5902-04 | 00023-5902 | Triptorelin Pamoate | Trelstar | Hormonal Therapy | GnRH Agonist | Jun 15, 2000 | In Use | ||||
| 62935-0452-45 | 62935-0452 | Leuprolide Acetate | Eligard | Hormonal Therapy | GnRH Agonist | Subcutaneous | Jan 23, 2002 | Apr 26, 2019 | No Longer Used | ||
| 70720-0951-30 | 70720-0951 | Goserelin | ZOLADEX | 10.8 mg/1 | Hormonal Therapy | GnRH Agonist | Subcutaneous | Jan 26, 2018 | In Use | ||
| 52544-0156-02 | 52544-0156 | Triptorelin Pamoate | Trelstar | 22.5 mg/2mL | Hormonal Therapy | GnRH Agonist | Intramuscular | Mar 11, 2010 | Oct 31, 2018 | No Longer Used | |
| 62935-0756-80 | 62935-0756 | Leuprolide acetate | Eligard | 7.5 mg/.25mL | Hormonal Therapy | GnRH Agonist | Subcutaneous | Nov 1, 2023 | In Use | ||
| 55150-0478-01 | 55150-0478 | LEUPROLIDE ACETATE | LEUPROLIDE ACETATE | Hormonal Therapy | GnRH Agonist | Jun 6, 2022 | In Use | ||||
| 00074-3683-03 | 00074-3683 | Leuprolide Acetate | Lupron Depot | Hormonal Therapy | GnRH Agonist | Dec 23, 1995 | In Use | ||||
| 00121-2106-02 | 00121-2106 | Leuprolide acetate | Leuprolide acetate | 5.0 mg/1ml | Hormonal Therapy | GnRH Agonist | Subcutaneous | Feb 1, 2025 | In Use | ||
| 52544-0189-76 | 52544-0189 | Triptorelin Pamoate | Trelstar | Hormonal Therapy | GnRH Agonist | Jun 15, 2000 | Oct 31, 2018 | No Longer Used | |||
| 62935-0752-75 | 62935-0752 | Leuprolide Acetate | Eligard | Hormonal Therapy | GnRH Agonist | Subcutaneous | May 15, 2002 | Apr 26, 2019 | In Use | ||
| 69448-0023-63 | 69448-0023 | LEUPROLIDE | CAMCEVI | 42.0 mg/.37g | Hormonal Therapy | GnRH Agonist | Subcutaneous | May 19, 2025 | In Use | ||
| 69097-0909-50 | 69097-0909 | Leuprolide acetate | LEUPROLIDE ACETATE DEPOT | Hormonal Therapy | GnRH Agonist | Jul 15, 2022 | In Use | ||||
| 62935-0227-10 | 62935-0227 | Leuprolide acetate | Eligard | 22.5 mg/.375mL | Hormonal Therapy | GnRH Agonist | Subcutaneous | Nov 27, 2023 | In Use | ||
| 70121-2537-06 | 70121-2537 | Leuprolide acetate | Leuprolide acetate | Hormonal Therapy | GnRH Agonist | Subcutaneous | Nov 7, 2022 | In Use | |||
| 83634-0454-61 | 83634-0454 | Leuprolide acetate | Leuprolide Acetate | 5.0 mg/mL | Hormonal Therapy | GnRH Agonist | Subcutaneous | Mar 15, 2025 | In Use | ||
| 55566-1050-01 | 55566-1050 | Nadofaragene firadenovec-vncg | ADSTILADRIN | 300000000000.0 {VP}/mL | Immunotherapy | Gene Therapy | IFN⍺2b | Intravesical | Sep 5, 2023 | In Use | |
| 55566-1050-02 | 55566-1050 | Nadofaragene firadenovec-vncg | ADSTILADRIN | 300000000000.0 {VP}/mL | Immunotherapy | Gene Therapy | IFN⍺2b | Intravesical | Oct 13, 2025 | In Use | |
| 72187-0401-01 | 72187-0401 | Tagraxofusp | Elzonris | 1000.0 ug/mL | Immunotherapy | Fusion Protein | IL3/ CD123 | Intravenous | Jan 18, 2019 | In Use | |
| 00310-4715-11 | 00310-4715 | IV Solution Stabilizer for Lumoxiti | IV Solution Stabilizer for Lumoxiti | 6.5 mg/mL | Ancillary Therapy | Excipient | Intravenous | Oct 24, 2018 | In Use | ||
| 54569-4908-00 | 54569-4908 | Estradiol | Estradiol | 2.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Oct 28, 1997 | In Use | ||
| 50090-7481-00 | 50090-7481 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Dec 20, 2024 | In Use | ||
| 57377-0050-01 | 57377-0050 | Estradiol pellet | Estra-50 | 50.0 mg/1 | Hormonal Therapy | Estrogen | Subcutaneous | Jan 1, 2017 | In Use | ||
| 42023-0134-01 | 42023-0134 | Estradiol Valerate | Estradiol Valerate | 10.0 mg/mL | Hormonal Therapy | Estrogen | Intramuscular | Jun 1, 2012 | Feb 28, 2016 | No Longer Used |
Found 12250 results — Export these results
Home